Protecting Science. Advancing HIV Prevention. Preparing for What's Next. | New AVAC Resources

AVAC’s Stacey Hannah and Mitchell Warren remind us in Think Global Health that "at a moment when scientific progress is advancing, advocates, researchers, policymakers, and communities should push back against politically motivated, fringe, antivaccine sentiments that threaten decades of investment to develop the tool that would finally break the back of the epidemic.” 

The introduction of injectable lenacapavir for HIV PrEP (LEN) is underway–in some places at least. To ensure communities remain at the center of LEN rollout, this new Advocates' Checklist for Lenacapavir for PrEP Introduction is an immediate, actionable blueprint designed to help civil society organizations (CSOs) and global health advocates pressure-test government commitments, map implementation bottlenecks and demand equitable access. The checklist is designed to support faster, community-centered rollout ahead of broader generic availability in 2027, as described by the co-chairs of the Civil Society Caucus of the Coalition to Accelerate Access to Long-Acting PrEP and AVAC staff.

Join AVAC and partners to hear the impact stories of ten years of the Coalition to Accelerate and Support Prevention Research (CASPR). Established in 2016, CASPR was funded by the United States Agency for International Development (USAID) and designed by AVAC with leading civil society partners to influence HIV prevention research, policy and implementation. With attacks on global health and shrinking resources dismantling hard-won gains, the lessons from CASPR are a call for continued action: strong, community-led advocacy is indispensable to safeguard the future of HIV prevention.

Join The Choice Agenda and Hunter College’s Sarit Golub for a participatory discussion on implementation science – including opportunities, pitfalls and ways in which community leadership is essential to success. What are the different types of implementation science, and how do we move forward with community and front-line implementers at the helm? 

ICYMI, AVAC launched the AI & HIV Newsletter, a new quarterly resource highlighting the latest tools, research, policy developments and news at the intersection of AI and HIV. Designed for advocates and the global community and guided by an expert advisory board, the newsletter provides readers with the information and resources to engage with AI in ways that strengthen equity, protect individuals and communities and prioritize their inclusion, and ensure that technological innovation advances the HIV response.